Bilateral De Quervain Syndrome after Aromatase Inhibitor Administration: A Case Report and Review of the Literature
Aromatase inhibitors are widely used as one of the main treatment options of both early and advanced hormone receptor-positive breast cancer in postmenopausal women. Unfortunately, musculoskeletal symptoms are often presented in patients treated with aromatase inhibitors (AIs), and, although the pat...
Saved in:
Main Authors: | Konstantinos Papadimitriou, Panteleimon Kountourakis, Emmanouil Morakis, Vassilios Vassiliou, Vasileios Barbounis, Alexandros Ardavanis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/810428 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Precocious Puberty as a Complication of Therapy with Adrenocorticotropin (ACTH) and an Aromatase Inhibitor for Refractory Nephrotic Syndrome
by: Sungeeta Agrawal, et al.
Published: (2019-01-01) -
Sex Reversal of Red Tilapia (Oreochromis sp.) by Larval Immersion using Aromatase Inhibitor
by: M. Agus Sudrajat, et al.
Published: (2007-01-01) -
Strategies for preventing and managing osteoporosis in elderly breast cancer patients undergoing aromatase inhibitor therapy
by: Andi Tian, et al.
Published: (2025-01-01) -
Comprehensive Insights into De Quervain’s Tenosynovitis: From Etiology to Rehabilitation
by: Piotr Charzewski, et al.
Published: (2025-02-01) -
Efficacy of Intra Sheath Corticosteroid Injection in Treatment of De Quervain Disease
by: Qasim Mahmood, et al.
Published: (2024-09-01)